475 related articles for article (PubMed ID: 23481523)
1. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
[TBL] [Abstract][Full Text] [Related]
2. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
[TBL] [Abstract][Full Text] [Related]
3. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
4. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
5. Community care in England: reducing socioeconomic inequalities in heart failure.
Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
Circulation; 2012 Aug; 126(9):1050-7. PubMed ID: 22837162
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
7. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
8. Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
Redfors B; Angerås O; Råmunddal T; Petursson P; Haraldsson I; Dworeck C; Odenstedt J; Ioaness D; Ravn-Fischer A; Wellin P; Sjöland H; Tokgozoglu L; Tygesen H; Frick E; Roupe R; Albertsson P; Omerovic E
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175358
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic tests, drug prescriptions, and follow-up patterns after incident heart failure: A cohort study of 93,000 UK patients.
Conrad N; Judge A; Canoy D; Tran J; O'Donnell J; Nazarzadeh M; Salimi-Khorshidi G; Hobbs FDR; Cleland JG; McMurray JJV; Rahimi K
PLoS Med; 2019 May; 16(5):e1002805. PubMed ID: 31112552
[TBL] [Abstract][Full Text] [Related]
10. Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry.
Nguyen HL; Goldberg RJ; Gore JM; Fox KA; Eagle KA; Gurfinkel EP; Spencer FA; Reed G; Quill A; Anderson FA
Coron Artery Dis; 2010 Sep; 21(6):336-44. PubMed ID: 20661139
[TBL] [Abstract][Full Text] [Related]
11. Trends and variations in the prescribing of secondary preventative cardiovascular therapies for non-ST elevation myocardial infarction (NSTEMI) in Malaysia.
Venkatason P; Zaharan NL; Ismail MD; Wan Ahmad WA; Mahmood Zuhdi AS
Eur J Clin Pharmacol; 2018 Jul; 74(7):953-960. PubMed ID: 29582106
[TBL] [Abstract][Full Text] [Related]
12. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
13. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
14. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
15. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
17. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
18. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
19. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
[TBL] [Abstract][Full Text] [Related]
20. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]